All practice questions

Question 581Question →

Match the following clinical exposure scenarios with their most appropriate post-exposure prophylaxis or empiric treatment regimen.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Meningococcal contact requires Rifampin/Ciprofloxacin/Ceftriaxone; Cat bite requires Amoxicillin-clavulanate; High-risk tick bite requires single-dose Doxycycline; HIV needlestick requires Three-drug antiretroviral therapy.

Each exposure corresponds to a specific, evidence-based prophylactic or early treatment regimen designed to eradicate the most likely transmitted pathogen before an active infection becomes established.

Step-by-Step Solution

1

Analyze each exposure scenario to identify the primary pathogen of concern.

Pathogens identified include Neisseria meningitidis, Pasteurella multocida, Borrelia burgdorferi, and HIV.

Accurate pathogen identification dictates the choice of targeted prophylaxis.

2

Select the guideline-recommended prophylactic or empiric regimen for each identified pathogen risk.

Matched the appropriate antimicrobial or antiretroviral regimen to each specific exposure.

Prophylaxis must target the specific organism's susceptibilities to effectively prevent disease development.

Key Concept

Post-exposure prophylaxis and early empiric treatment regimens for common infectious exposures.

Question 582Question →

Match each patient's clinical presentation and peripheral blood smear findings with the most appropriate definitive antimalarial treatment regimen.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct matches synthesize the Plasmodium species identified via smear morphology, clinical severity, regional resistance patterns, and the presence of a hypnozoite phase to assign the definitive pharmacological regimen.

The correct pairings require precise synthesis of microbiologic findings (smear morphology), clinical status (severe vs. uncomplicated), and geographic resistance data. Severe P. falciparum requires IV artesunate. Uncomplicated CQ-resistant P. falciparum requires oral ACT. P. vivax requires CQ plus primaquine for hypnozoites. P. malariae requires only CQ.

Step-by-Step Solution

1

Evaluate the first scenario (Nigeria).

Identified as severe P. falciparum based on >10% parasitemia, CNS symptoms, acute kidney injury, and crescent gametocytes.

Determining species and severity dictates the urgent need for intravenous artesunate therapy.

2

Evaluate the second scenario (Honduras).

Identified as P. vivax based on 48-hour fevers, enlarged RBCs, and Schüffner's dots.

P. vivax has a dormant liver stage (hypnozoites) requiring specific anti-relapse therapy with primaquine in addition to chloroquine.

3

Evaluate the third scenario (Thailand).

Identified as uncomplicated P. falciparum from a chloroquine-resistant region based on 1.5% parasitemia and appliqué rings.

Requires an oral artemisinin-based combination therapy; no primaquine is needed as there is no liver stage.

4

Evaluate the fourth scenario (Caribbean).

Identified as P. malariae based on 72-hour fever cycles and band-like trophozoites.

Indicates a chloroquine-sensitive strain with no liver stage, treated definitively with chloroquine monotherapy.

Key Concept

Diagnosis and targeted pharmacotherapy of malaria based on Plasmodium species morphology, clinical severity, geographic resistance patterns, and the presence of a hypnozoite phase.

Estimated Time:2m 30s

Question 583Question →

Match each patient vignette presenting with a complex bleeding or thrombotic complication to the most appropriate targeted therapy or management strategy.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Vignette 1 matches 'Administer recombinant factor VIIa or activated prothrombin complex concentrate'. Vignette 2 matches 'Initiate lifelong therapeutic anticoagulation with a vitamin K antagonist'. Vignette 3 matches 'Administer von Willebrand factor concentrate and specifically avoid desmopressin (DDAVP)'. Vignette 4 matches 'Administer platelet transfusions for acute severe bleeding episodes'.

Each correct pairing directly links a highly specific and complex laboratory profile to its exact diagnosis and corresponding life-saving or disease-modifying therapy, requiring multi-step pathophysiologic reasoning.

Step-by-Step Solution

1

Analyze the mixing study and coagulation profile in the first vignette.

A time-dependent inhibitor is identified, characteristic of an acquired factor VIII autoantibody.

To determine that standard factor VIII replacement will fail and bypassing agents are required.

2

Evaluate the coagulation profile and clinical history in the second vignette.

A phospholipid-dependent immediate inhibitor is identified in a patient with DVT and miscarriages, diagnosing Antiphospholipid Syndrome.

To identify that lifelong vitamin K antagonist anticoagulation is required for secondary thrombosis prevention.

3

Assess the platelet aggregometry and VWF studies in the third vignette.

Enhanced aggregation with low-dose ristocetin confirms Type 2B VWD.

To recognize that DDAVP is contraindicated and exogenous VWF concentrate must be utilized.

4

Analyze the peripheral smear and aggregation studies in the fourth vignette.

Macrothrombocytopenia with absent ristocetin aggregation unresponsive to normal plasma confirms Bernard-Soulier syndrome.

To determine that because the defect is intrinsic to the platelets, platelet transfusion is the definitive therapy.

Key Concept

Interpretation of advanced coagulation assays (immediate vs. incubated mixing studies, phospholipid dependence) and specialized platelet aggregometry is required to diagnose complex acquired and congenital hematologic disorders and select appropriate targeted therapies.

Estimated Time:3m 0s

Question 584Question →

Match each pediatric patient presenting for a clinical visit with the most appropriate next step in their preventive care or immunization management.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct matches align specific high-risk pediatric scenarios with their respective modified immunization or post-exposure prophylaxis protocols based on altered immunocompetence, household exposures, and age constraints.

Each match correctly applies ACIP and Bright Futures guidelines for exceptional pediatric populations. The rules for live vaccines depend heavily on the mechanism of immunosuppression (cellular vs. passive antibody), the route of vaccine administration (parenteral vs. mucosal), and the exact timeline of exposure.

Step-by-Step Solution

1

Evaluate the 12-month-old with severe T-cell lymphopenia.

Match with withholding all live-attenuated vaccines.

Patients with severe cellular immunodeficiency cannot mount an adequate response to, and cannot safely clear, the attenuated viruses in live vaccines. Administration can cause fatal disseminated vaccine-strain infection.

2

Evaluate the 12-month-old with in utero infliximab exposure.

Match with administering MMR and varicella vaccines without delay.

IgG monoclonal antibodies cross the placenta. Infants are considered immunosuppressed for the first 6 months of life, contraindicating early live vaccines like rotavirus. At 12 months, the infant's immune system is normal, and MMR/varicella are safe.

3

Evaluate the 15-month-old sibling of a bone marrow transplant recipient.

Match with administering MMR/varicella but avoiding LAIV.

To protect immunocompromised family members, healthy contacts should be fully immunized, including with MMR and varicella. The only exception is LAIV (nasal flu spray), which is contraindicated because the attenuated virus can be shed and transmitted to the transplant recipient.

4

Evaluate the 4-month-old who received IVIG 4 weeks ago.

Match with administering the scheduled oral rotavirus vaccine.

IVIG provides passive serum IgG that interferes with injected live vaccines (MMR, varicella), necessitating a delay. It does not interfere with mucosal IgA responses in the gastrointestinal tract, so the live oral rotavirus vaccine is given on its strict age-based schedule.

5

Evaluate the completely unimmunized 7-year-old with a dirty wound.

Match with administering Tdap and TIG.

Unknown or <3 doses of tetanus toxoid plus a dirty wound requires both active (vaccine) and passive (TIG) prophylaxis. At age 7 years, the correct formulation is Tdap, as DTaP is contraindicated at age 7 and older.

Key Concept

Complex immunization management requires understanding the distinctions between cellular vs. humoral immunodeficiency, parenteral vs. mucosal live vaccines, and strict age cutoffs for specific vaccine formulations.

Question 585Question →

Macrosomic neonates are at increased risk for birth trauma, particularly during difficult or operative vaginal deliveries. Match each characteristic clinical presentation observed during the newborn physical examination with its most likely traumatic etiology.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The presentations match as follows: 'waiter's tip' posture matches upper trunk injury (Erb palsy), claw hand with Horner syndrome matches lower trunk injury (Klumpke palsy), shoulder crepitus matches clavicular fracture, and asymmetric breathing matches phrenic nerve injury.

Each clinical presentation is a classic manifestation of a specific birth trauma. Accurate diagnosis requires localizing the neurological deficit (proximal vs. distal muscles) and identifying associated structural findings (crepitus, sympathetic deficit, or diaphragmatic paralysis).

Step-by-Step Solution

1

Analyze the pattern of motor deficits in the newborn's upper extremity.

Proximal weakness with an intact grasp indicates C5-C6 involvement; distal weakness with an absent grasp indicates C8-T1 involvement.

Different roots of the brachial plexus innervate specific muscle groups, allowing for precise clinical localization.

2

Assess for associated non-motor or extra-extremity physical signs.

Ipsilateral ptosis/miosis points to T1 sympathetic chain involvement; respiratory distress points to cervical roots C3-C5; crepitus points to a mechanical bone injury.

Recognizing associated findings helps differentiate isolated brachial plexus injuries from those involving adjacent structures or primary bone trauma.

Key Concept

Differentiating neonatal birth traumas based on characteristic physical examination findings and neurological localization.

Question 586Question →

Review the following physical examination findings of skin lesions in newborn infants. Associate each dermatologic presentation with its corresponding diagnosis.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The presentations match as follows: The infant with eosinophil-filled pustules has Erythema toxicum neonatorum. The newborn with neutrophil-filled pustules and hyperpigmented macules has Transient neonatal pustular melanosis. The infant with pearly white facial papules has Milia. The 21-day-old with facial papules lacking comedones has Neonatal cephalic pustulosis.

The correct pairings rely on identifying the classic distinguishing features of benign neonatal rashes. Erythema toxicum neonatorum typically appears a few days after birth and features eosinophil-filled pustules on an erythematous base. In contrast, Transient neonatal pustular melanosis is present at birth, lacks an erythematous base, contains neutrophils, and leaves hyperpigmented macules. Milia are simple keratin-filled cysts appearing as pearly white papules. Neonatal cephalic pustulosis presents later (around 3 weeks) with facial papules that specifically lack the comedones seen in true acne.

Step-by-Step Solution

1

Analyze the first presentation involving an erythematous rash with eosinophil-filled pustules appearing at 48 hours of life.

This pattern points to a common, benign newborn rash.

The presence of eosinophils and an erythematous base are the classic hallmarks of Erythema toxicum neonatorum.

2

Evaluate the second presentation involving neutrophil-filled pustules present at birth that leave hyperpigmented macules.

This indicates a specific transient eruption seen in neonates.

The lack of surrounding erythema, presence at birth, and neutrophil content define Transient neonatal pustular melanosis.

3

Assess the third presentation involving 1-to-2 millimeter pearly white papules on the face.

This indicates retention of keratin and sebaceous material.

These pinpoint white papules are characteristic of Milia.

4

Review the fourth presentation involving inflammatory facial papules at 3 weeks of age without comedones.

This indicates a condition similar to acne but lacking true comedones.

The timing and absence of comedones are the key distinguishing features of Neonatal cephalic pustulosis.

Key Concept

Differentiating benign neonatal skin eruptions based on timing of onset, physical appearance, and cellular contents of pustules.

Question 587Question →

A pediatric clinic is auditing patient records to ensure adherence to specialized immunization guidelines for high-risk patients. Match each pediatric patient scenario with the most appropriate vaccine indication, absolute contraindication, or management step.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct pairings match each specialized clinical scenario to its corresponding vaccine management guideline based on structural defects (PPSV23 for cochlear implants), functional asplenia (MenB starting at age 10), severe cellular immunodeficiency (absolute MMR contraindication), passive immunity interference (11-month live vaccine deferral post-IVIG), and specific allergies (HepB/HPV contraindication for yeast allergy).

Each patient requires a specialized modification to the routine immunization schedule. Cochlear implants necessitate PPSV23 due to an increased risk of pneumococcal meningitis from potential CSF leaks. Functional asplenia requires MenB starting at age 10. Severe T-cell defects are absolute contraindications to live vaccines (MMR). High-dose IVIG for Kawasaki disease requires an 11-month temporary deferral of live vaccines (yielding 8 months remaining if 3 months have passed). Yeast anaphylaxis strictly contraindicates the HepB and HPV vaccines.

Step-by-Step Solution

1

Identify the underlying high-risk condition or status in each pediatric patient.

Recognize the presence of a cochlear implant, functional asplenia (sickle cell), severe T-cell deficiency, recent high-dose IVIG, and baker's yeast anaphylaxis.

Vaccine indications and contraindications depend heavily on these specific historical and clinical details rather than chronological age alone.

2

Determine appropriate pneumococcal and meningococcal vaccine indications for structural and functional defects.

The 4-year-old with a cochlear implant needs PPSV23. The 10-year-old with sickle cell anemia is newly eligible to start the MenB series.

Cochlear implants selectively increase pneumococcal meningitis risk (PPSV23 indicated >2 yrs). Asplenia increases broad encapsulated risk, and MenB is specifically approved and initiated at age 10.

3

Differentiate between temporary deferrals and absolute contraindications for live-attenuated vaccines.

The infant with severe T-cell deficiency has an absolute contraindication to MMR. The child who received IVIG 3 months ago requires an 11-month total deferral (8 additional months remaining).

Cellular immunodeficiency carries a fatal risk of vaccine-strain infection (absolute). Passive antibodies from IVIG merely blunt the immune response without causing harm (temporary).

4

Identify vaccine components related to specific severe allergies.

The adolescent with baker's yeast anaphylaxis cannot receive Hepatitis B or HPV vaccines.

Both of these vaccines are propagated in Saccharomyces cerevisiae and contain residual yeast proteins.

Key Concept

Vaccine modifications in special pediatric populations (immunocompromised, anatomic/functional defects, and specific allergies)

Estimated Time:2m 0s

Question 588Question →

Match each inpatient clinical scenario with the most appropriate targeted pharmacologic intervention based on current clinical guidelines.

Click a left item, then click its matching right item

Show answer & explanation

Answer

ESBL pneumonia is treated with meropenem; invasive pulmonary aspergillosis presenting with a halo sign requires voriconazole; severe C. difficile infection mandates oral fidaxomicin; and high-MIC MRSA endocarditis requires switching to daptomycin.

Each clinical scenario requires a critical deviation from standard empiric broad-spectrum therapy based on diagnostic clues: carbapenems for confirmed ESBL exposure, voriconazole for the characteristic fungal 'halo sign', fidaxomicin for severe toxin-mediated colitis, and daptomycin for highly resistant MRSA bacteremia.

Step-by-Step Solution

1

Analyze each patient's clinical presentation, laboratory data, and radiographic imaging to definitively diagnose the specific pathogen or pathological complication.

Identified: ESBL Klebsiella pneumonia, invasive pulmonary aspergillosis, severe C. difficile colitis, and high-MIC MRSA endocarditis.

Accurate identification of the underlying pathology and specific resistance mechanism is mandatory before selecting definitive targeted therapy.

2

Determine the optimal targeted therapeutic agent based on antimicrobial stewardship principles, site of infection, and resistance patterns.

Matched the ESBL pathogen to carbapenems, aspergillosis to voriconazole, severe C. difficile to fidaxomicin, and high-MIC MRSA to daptomycin.

Prescribing inappropriate antimicrobial therapies leads to treatment failure, compounding toxicity, and the promotion of further multidrug resistance.

Key Concept

Targeted antimicrobial therapy for severe, resistant, and opportunistic nosocomial infections

Question 589Question →

Evaluate the following neonatal clinical presentations characterized by gastrointestinal obstruction or feeding intolerance. Match each specific presentation to its precise underlying embryologic or pathophysiologic etiology.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The presentations map to the following pathophysiologies: Vignette 1 is duodenal atresia (failure of recanalization). Vignette 2 is jejunoileal atresia (intrauterine vascular compromise). Vignette 3 is Hirschsprung disease (arrested neural crest cell migration). Vignette 4 is meconium ileus (ATP-binding cassette transporter mutation).

Each neonate presents with a distinct form of gastrointestinal obstruction. The 'double bubble' in a Down syndrome infant represents duodenal atresia (failure of recanalization). The 'triple bubble' with maternal cocaine use represents jejunal atresia (mesenteric vascular accident). The transition zone on contrast enema represents Hirschsprung disease (failure of neural crest migration). The ground-glass density without air-fluid interfaces represents meconium ileus due to Cystic Fibrosis (mutation in CFTR, an ATP-binding cassette transporter).

Step-by-Step Solution

1

Analyze the first clinical presentation and radiographic findings.

The dysmorphic features (Down syndrome) and 'double bubble' sign on X-ray identify duodenal atresia.

Identifying the specific congenital anomaly is prerequisite to determining its embryologic origin. Duodenal atresia uniquely arises from a failure of the bowel lumen to recanalize.

2

Evaluate the second presentation involving maternal stimulant use.

Maternal cocaine use and multiple air-fluid levels/triple bubble sign identify jejunoileal atresia.

Cocaine causes severe vasoconstriction. In the fetus, this leads to mesenteric vascular accidents, which cause ischemic necrosis and subsequent atresia of the jejunum or ileum.

3

Examine the third presentation involving contrast enema findings.

Delayed meconium passage with a transition zone and reversed rectosigmoid ratio diagnoses Hirschsprung disease.

The aganglionic segment remains tonically contracted, causing a functional obstruction. This is due to the failure of neural crest cells to migrate completely to the distal hindgut.

4

Assess the final presentation involving a 'granular density' on X-ray.

The ground-glass appearance (Neuhauser sign) without air-fluid levels indicates meconium ileus, a complication of Cystic Fibrosis.

Thickened meconium prevents the formation of clear air-fluid interfaces. Cystic Fibrosis is caused by defective chloride transport via the CFTR protein (an ATP-binding cassette transporter).

Key Concept

Embryologic and pathophysiologic mechanisms of neonatal gastrointestinal obstructions.

Estimated Time:2m 30s

Question 590Question →

In the management of systemic autoimmune and inflammatory diseases, disease-modifying antirheumatic drugs (DMARDs) and biologic therapies are mainstays of treatment. However, their use is associated with unique adverse effects that require specific screening and monitoring strategies. Match each medication below with its most characteristic adverse effect profile or required screening parameter.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Hydroxychloroquine matches with retinopathy; Methotrexate matches with hepatotoxicity, stomatitis, and macrocytic anemia; Cyclophosphamide matches with hemorrhagic cystitis; Adalimumab matches with reactivation of latent tuberculosis.

The correct pairings align each rheumatologic medication with its well-established mechanism of toxicity and corresponding monitoring requirement. Hydroxychloroquine accumulates in the retina, causing maculopathy. Methotrexate depletes folate, leading to mucosal and hepatic toxicity. Cyclophosphamide's metabolite acrolein damages the bladder mucosa. Adalimumab inhibits TNF-alpha, which is essential for maintaining granulomas, thus risking the reactivation of latent tuberculosis.

Step-by-Step Solution

1

Identify the primary toxicity profile of Hydroxychloroquine.

Matches with retinopathy requiring regular ophthalmologic screening.

The drug binds to melanin in the retinal pigment epithelium, causing cumulative and potentially irreversible damage.

2

Identify the primary toxicity profile of Methotrexate.

Matches with hepatotoxicity, stomatitis, and macrocytic anemia.

It is a folate antimetabolite; its adverse effects are often mitigated by concurrent folic acid supplementation.

3

Identify the primary toxicity profile of Cyclophosphamide.

Matches with hemorrhagic cystitis and increased risk of bladder carcinoma.

The toxic metabolite acrolein concentrates in the urinary bladder. Mesna and adequate hydration are used for prophylaxis.

4

Identify the primary toxicity profile of Adalimumab.

Matches with reactivation of latent tuberculosis or fungal infections.

As a TNF-alpha inhibitor, it disrupts granuloma integrity, making pre-treatment screening for latent tuberculosis (e.g., interferon-gamma release assay) essential.

Key Concept

Pharmacologic adverse effects and monitoring requirements of DMARDs and biologic agents in rheumatologic diseases.

Question 591Question →

Correlate the following pediatric patient scenarios with the most appropriate targeted preventive care or immunization intervention.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Match the complement deficiency to the MenB vaccine, the older housing exposure to lead screening, the sickle cell disease to the PPSV23 vaccination, and the endemic region emigration to tuberculosis screening.

High-risk pediatric patients require precise modifications to standard preventive care. Asplenia (seen in sickle cell disease) necessitates PPSV23 to protect against encapsulated bacteria. Complement deficiencies require MenB to prevent severe meningococcal disease. Specific environmental and geographic exposures mandate targeted screening for lead toxicity and tuberculosis, respectively.

Step-by-Step Solution

1

Identify the primary underlying risk factor or exposure in each patient's clinical history.

Recognized complement deficiency, lead paint exposure risk, functional asplenia, and high-risk geographic origin.

Targeted preventive care relies on identifying specific risk factors that deviate from the standard, low-risk pediatric population.

2

Determine the indicated supplemental vaccine or screening test based on the identified risk.

Assigned MenB, lead testing, PPSV23, and TB screening to their respective clinical scenarios.

To correctly apply the guidelines from the Centers for Disease Control and Prevention and the American Academy of Pediatrics for high-risk patients.

Key Concept

Targeted preventive care and immunization schedules for high-risk pediatric populations.

Question 592Question →

Match each clinical vignette describing an adverse reaction to a packed red blood cell (pRBC) transfusion with the most appropriate next step in management.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Acute hemolytic reaction matches with aggressive IV hydration; Febrile non-hemolytic reaction matches with administering an antipyretic; TRALI matches with supportive respiratory care; Allergic reaction matches with pausing, giving antihistamines, and resuming; and TACO matches with administering intravenous furosemide.

Each transfusion reaction has a distinct pathophysiologic mechanism that dictates its classic clinical presentation and subsequent management. Immediate life-threatening events like ABO incompatibility (Acute Hemolytic) require fluids to save the kidneys. Inflammatory but benign events (Febrile Non-Hemolytic) require simple antipyretics. Immune-mediated lung injury (TRALI) requires strict supportive respiratory care, while hydrostatic lung injury (TACO) requires aggressive diuresis. Finally, mild IgE-mediated reactions (Allergic) uniquely allow for pausing, treating the symptoms, and finishing the transfusion.

Step-by-Step Solution

1

Identify the cause of flank pain and dark urine shortly after starting a transfusion.

Matches aggressive IV hydration.

Diagnosis is an acute hemolytic reaction; fluids are essential to prevent pigment nephropathy and renal failure.

2

Evaluate isolated fever and chills without hemodynamic instability.

Matches antipyretic administration.

Diagnosis is a febrile non-hemolytic reaction, requiring only symptom control after ruling out hemolysis.

3

Distinguish the cause of respiratory distress with pulmonary infiltrates but normal blood pressure.

Matches supportive respiratory care.

Diagnosis is TRALI; immune-mediated capillary permeability requires respiratory support, not diuresis.

4

Identify the significance of isolated urticaria and pruritus without systemic signs.

Matches administering antihistamines and resuming.

Diagnosis is a mild allergic reaction; the blood product can safely be utilized after symptom resolution.

5

Evaluate respiratory distress accompanied by hypertension and basilar crackles in an elderly patient.

Matches intravenous furosemide.

Diagnosis is TACO; the acute volume overload must be reversed with rapid diuresis.

Key Concept

Management and identification of acute blood transfusion reactions

Question 593Question →

Match each patient's clinical and microbiological presentation with the most appropriate targeted antimicrobial therapy.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Listeria monocytogenes pairs with ampicillin; ESBL-producing E. coli pairs with meropenem; invasive aspergillosis pairs with voriconazole; and MRSA pairs with vancomycin.

Each pathogen has a distinct, well-established first-line treatment. Ampicillin is uniquely active against Listeria. Carbapenems (meropenem) are stable against extended-spectrum beta-lactamases produced by resistant Gram-negative rods. Voriconazole is the antifungal of choice for invasive Aspergillus. Vancomycin provides reliable coverage for oxacillin-resistant staphylococci (MRSA).

Step-by-Step Solution

1

Identify the underlying pathogen described in each clinical vignette using key microbiological and serological terms.

Pathogens identified are Listeria monocytogenes, ESBL E. coli, Aspergillus species, and MRSA.

Accurate pathogen identification is required to select narrow, targeted antimicrobial therapy.

2

Determine the first-line targeted therapy for each identified organism.

Ampicillin for Listeria, meropenem for ESBL, voriconazole for Aspergillus, and vancomycin for MRSA.

Applying standard pharmacotherapy guidelines ensures effective treatment while adhering to antimicrobial stewardship principles.

Key Concept

Targeted Antimicrobial Therapy for Classic Pathogens

Estimated Time:1m 0s

Question 594Question →

Match each patient's clinical presentation and peripheral blood smear findings to the most likely underlying pathophysiologic mechanism.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct matches align classic hematologic presentations with their distinct pathophysiologies: TTP is due to ADAMTS13 deficiency, ITP is due to anti-platelet antibodies, Warm AIHA is due to anti-RBC antibodies, and G6PD deficiency limits protection against oxidative stress.

Each patient's clinical scenario and lab findings perfectly align with a specific hematologic mechanism. The TTP case matches ADAMTS13 deficiency; the ITP case matches anti-platelet antibodies; the AIHA case matches anti-RBC antibodies; and the drug-induced bite cell hemolysis matches G6PD deficiency.

Step-by-Step Solution

1

Analyze the first presentation: fever, confusion, microangiopathic hemolytic anemia (schistocytes), and thrombocytopenia with normal coagulation studies.

Identifies Thrombotic Thrombocytopenic Purpura (TTP).

TTP classically presents with this pentad (or partial pentad) and is driven by ADAMTS13 deficiency.

2

Analyze the second presentation: isolated thrombocytopenia with large platelets and normal coagulation studies in an otherwise healthy young woman.

Identifies Immune Thrombocytopenia (ITP).

ITP is an autoimmune condition caused by anti-GpIIb/IIIa IgG antibodies.

3

Analyze the third presentation: hemolytic anemia with spherocytes and a positive direct antiglobulin test (DAT) in a patient with CLL.

Identifies Warm Autoimmune Hemolytic Anemia (AIHA).

Warm AIHA is mediated by IgG antibodies against RBC antigens and is frequently associated with CLL.

4

Analyze the fourth presentation: acute hemolytic anemia with bite cells following exposure to an oxidative stressor (sulfamethoxazole-trimethoprim).

Identifies Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.

G6PD deficiency impairs the RBC's ability to produce NADPH, leading to oxidative damage when exposed to sulfa drugs.

Key Concept

The diagnosis of hematologic disorders requires integrating clinical findings, specific peripheral blood smear abnormalities, and an understanding of the underlying autoimmune or enzymatic pathophysiology.

Estimated Time:2m 0s

Question 595Question →

Match each clinical vignette describing a patient with a hypercoagulable or thrombotic disorder to the underlying pathophysiologic mechanism responsible for their presentation.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Factor V Leiden matches to the inherited mutation resisting natural anticoagulants; Antiphospholipid syndrome matches to autoantibodies affecting phospholipid assays; Polycythemia vera matches to the acquired JAK2 mutation; Warfarin-induced skin necrosis matches to the rapid depletion of a short half-life protein.

Each clinical scenario uniquely maps to a distinct mechanism of hypercoagulability. The presentation of APC resistance is exclusive to Factor V Leiden. The inhibitor pattern on mixing study that corrects with phospholipids is the defining laboratory feature of Lupus Anticoagulant. Pancytosis with low EPO and an atypical venous thrombosis points unequivocally to the JAK2 mutation in Polycythemia Vera. Finally, skin necrosis upon warfarin initiation is the classic presentation of a rapid, drug-induced decline in Protein C.

Step-by-Step Solution

1

Analyze the first vignette describing activated protein C (APC) resistance.

Identify Factor V Leiden, a condition caused by a missense mutation in Factor V that prevents its normal cleavage and degradation by APC.

Connecting the diagnostic laboratory finding (APC resistance) to its fundamental genetic etiology.

2

Analyze the second vignette describing recurrent miscarriages and a specific coagulation mixing study profile.

Identify Lupus Anticoagulant (Antiphospholipid Syndrome), where autoantibodies prolong aPTT in vitro (inhibitor pattern) but correct with excess phospholipids.

Distinguishing between factor deficiencies and specific autoimmune inhibitors using standard mixing studies.

3

Analyze the third vignette detailing portal vein thrombosis, aquagenic pruritus, and pancytosis with low EPO.

Diagnose Polycythemia Vera, a myeloproliferative neoplasm caused by an acquired JAK2 tyrosine kinase mutation.

Recognizing the classic clinical presentation of PV and linking it to its molecular basis.

4

Analyze the fourth vignette describing necrotic skin lesions occurring shortly after starting a new oral anticoagulant.

Identify warfarin-induced skin necrosis, which occurs due to the rapid decline of Protein C before other procoagulant factors fall.

Linking the adverse drug reaction timeline to the pharmacokinetics of vitamin K-dependent factors.

Key Concept

Pathophysiology and diagnostic hallmarks of acquired and inherited hypercoagulable states (Factor V Leiden, Antiphospholipid Syndrome, Polycythemia Vera, and Protein C deficiency/Warfarin necrosis).

Estimated Time:2m 0s

Question 596Question →

Match each patient's clinical presentation with the most likely characteristic finding on muscle biopsy.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct matches align Inclusion Body Myositis with rimmed vacuoles, Dermatomyositis with perifascicular atrophy, Polymyositis with CD8+ T cell endomysial invasion, and Immune-Mediated Necrotizing Myopathy with necrosis lacking significant inflammation.

Each idiopathic inflammatory myopathy possesses distinct clinical and histopathologic features. Dermatomyositis is characterized by humoral-mediated perivascular inflammation resulting in perifascicular atrophy. Polymyositis involves direct T-cell cytotoxicity against muscle fibers, appearing as endomysial CD8+ cells. Inclusion body myositis uniquely presents in older males with asymmetric distal weakness and shows rimmed vacuoles. Immune-mediated necrotizing myopathy features profound myonecrosis with scant inflammation.

Step-by-Step Solution

1

Analyze the demographic and clinical features of each patient to identify the specific inflammatory myopathy.

Diagnoses established: left_1 is Inclusion Body Myositis (IBM), left_2 is Dermatomyositis (DM), left_3 is Polymyositis (PM), left_4 is Immune-Mediated Necrotizing Myopathy (IMNM).

Age, symmetry, distal vs. proximal involvement, and the presence or absence of skin findings/autoantibodies reliably differentiate the idiopathic inflammatory myopathies clinically.

2

Correlate each identified myopathy with its primary underlying immunopathologic mechanism.

DM is a humoral microangiopathy (perimysial), PM/IBM are cytotoxic T-cell processes (endomysial), and IMNM is an antibody-mediated necrotizing process.

Understanding the pathophysiology is essential to predicting the histologic appearance on biopsy.

3

Select the histologic description that matches the pathophysiology of the condition.

IBM matches rimmed vacuoles; DM matches perifascicular atrophy; PM matches CD8+ endomysial invasion; IMNM matches necrosis without inflammation.

Muscle biopsy remains the definitive gold standard for confirming specific subtypes of inflammatory myopathies.

Key Concept

Clinicopathologic correlation of idiopathic inflammatory myopathies

Estimated Time:2m 0s

Question 597Question →

Neonatal respiratory disorders frequently present with similar signs of respiratory distress, including tachypnea, grunting, and retractions, but their underlying mechanisms differ significantly. Match each of the following neonatal respiratory disorders with its primary underlying pathophysiology.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Transient tachypnea of the newborn is caused by delayed clearance of fetal alveolar fluid. Respiratory distress syndrome is caused by a deficiency of surfactant. Meconium aspiration syndrome is caused by airway obstruction and chemical pneumonitis from inhaled fetal stool. Bronchopulmonary dysplasia is caused by an arrest of lung development and damage from prolonged mechanical ventilation.

Correctly matching these conditions demonstrates a foundational understanding of the distinct pathophysiologic mechanisms driving the most common causes of neonatal respiratory distress. This knowledge is essential for predicting the clinical course and selecting appropriate management (e.g., exogenous surfactant for RDS vs. supportive care for TTN).

Step-by-Step Solution

1

Analyze the pathophysiology of Transient tachypnea of the newborn (TTN).

Identify that TTN is associated with retained fetal lung fluid, matching it to delayed clearance.

During vaginal delivery, thoracic squeeze and endogenous catecholamines normally help clear lung fluid. Cesarean delivery or rapid labor bypasses this, causing TTN.

2

Analyze the pathophysiology of Respiratory distress syndrome (RDS).

Identify that RDS is characterized by high surface tension in the alveoli due to lack of surfactant.

Premature infants have immature type II pneumocytes that cannot produce adequate surfactant, leading to microatelectasis.

3

Analyze the pathophysiology of Meconium aspiration syndrome (MAS).

Identify that MAS involves the inhalation of meconium-stained amniotic fluid.

Meconium is fetal stool. Its aspiration causes a ball-valve effect leading to air trapping, as well as a severe chemical pneumonitis.

4

Analyze the pathophysiology of Bronchopulmonary dysplasia (BPD).

Identify that BPD is a chronic complication rather than an acute delivery room event.

BPD develops in premature infants who require prolonged respiratory support, which inadvertently causes inflammatory damage and arrests normal alveolarization.

Key Concept

Pathophysiology of neonatal respiratory distress

Question 598Question →

Secondary hypertension should be suspected in patients presenting with resistant hypertension, severe blood pressure elevations, or specific clinical manifestations. Match each patient vignette with the most appropriate initial diagnostic screening test to evaluate the underlying etiology.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Pheochromocytoma screens with metanephrines, primary hyperaldosteronism with the aldosterone-to-renin ratio, renal artery stenosis with duplex ultrasonography, and Cushing syndrome with the dexamethasone suppression test.

Secondary hypertension requires targeted testing based on clinical suspicion to avoid unnecessary and expensive diagnostic evaluations. The pairings correctly align each classic clinical presentation with its respective gold-standard initial screening modality as recommended by current clinical guidelines.

Step-by-Step Solution

1

Analyze the first vignette to identify the classic triad of pheochromocytoma.

Recognized symptoms of headache, tachycardia, and diaphoresis.

Matching these symptoms points directly to catecholamine excess, prompting the selection of plasma free metanephrines.

2

Evaluate the second vignette focusing on the electrolyte abnormality.

Identified spontaneous hypokalemia in a hypertensive patient.

This combination is highly suspicious for primary hyperaldosteronism, evaluated initially by checking the aldosterone-to-renin ratio.

3

Assess the third vignette for cardiovascular complications.

Recognized flash pulmonary edema in the setting of acute-on-chronic hypertension and atherosclerosis.

These findings are hallmark signs of renal artery stenosis, which is non-invasively screened using renal artery Doppler ultrasonography.

4

Review the fourth vignette for physical stigmata of endocrine disease.

Identified signs of hypercortisolism (striae, adiposity, osteopenia).

These physical examination findings indicate Cushing syndrome, requiring screening with an overnight dexamethasone suppression test.

Key Concept

Screening modalities for secondary causes of hypertension based on specific clinical presentations.

Question 599Question →

Match each patient's clinical scenario regarding malaria prevention or treatment with the most appropriate targeted pharmacotherapy.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct matches require pairing the pregnant traveler with Mefloquine, the P. vivax patient with Primaquine, the severe P. falciparum patient with Intravenous artesunate, and the uncomplicated P. falciparum patient with Artemether-lumefantrine.

Malaria management is highly specific to the clinical context. Mefloquine is the safe and recommended chemoprophylaxis for pregnant women traveling to chloroquine-resistant areas. Primaquine specifically targets the dormant liver hypnozoites of Plasmodium vivax to prevent relapse. Severe Plasmodium falciparum malaria (indicated by high parasitemia, confusion, and organ failure) requires emergent intravenous artesunate. Uncomplicated Plasmodium falciparum can be safely managed with oral artemisinin-based combination therapies, such as artemether-lumefantrine.

Step-by-Step Solution

1

Evaluate the clinical status and species of malaria for each patient.

Patients are categorized into: prophylaxis in pregnancy, P. vivax hypnozoite eradication, severe P. falciparum, and uncomplicated P. falciparum.

Malaria treatment and prophylaxis algorithms depend heavily on clinical severity, Plasmodium species, local resistance patterns, and patient-specific factors.

2

Determine the appropriate regimen for the pregnant traveler.

Mefloquine is selected.

Mefloquine is the only recommended chemoprophylaxis for chloroquine-resistant areas that is safe in all trimesters of pregnancy. Doxycycline is teratogenic, and atovaquone-proguanil lacks sufficient safety data.

3

Determine the appropriate regimen to eradicate P. vivax hypnozoites.

Primaquine is selected.

P. vivax and P. ovale have dormant liver stages (hypnozoites) that standard blood schizonticides do not kill. Primaquine (or tafenoquine) is required to prevent relapse, provided the patient has normal G6PD levels.

4

Determine the appropriate therapy for severe P. falciparum malaria.

Intravenous artesunate is selected.

Severe malaria (defined by parasitemia >5%, altered mental status, renal failure, or respiratory distress) requires emergent parenteral therapy with intravenous artesunate to rapidly clear the parasite burden.

5

Determine the appropriate therapy for uncomplicated P. falciparum malaria.

Artemether-lumefantrine is selected.

Uncomplicated falciparum malaria in a chloroquine-resistant region is best treated with an oral artemisinin-based combination therapy (ACT).

Key Concept

Pharmacotherapy for malaria depends on the severity of illness, Plasmodium species, local resistance patterns, and patient-specific contraindications such as pregnancy or G6PD deficiency.

Question 600Question →

Match each of the following pediatric clinical vignettes describing an acute osteoarticular presentation with the most likely responsible infectious agent.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct pairings align the adolescent triad of tenosynovitis/dermatitis/arthritis with Neisseria gonorrhoeae, the sickle cell patient's bone infection with Salmonella species, the unimmunized toddler's Gram-negative joint aspirate with Haemophilus influenzae type b, and the healthy child's osteomyelitis with Staphylococcus aureus.

Each vignette contains distinct clues pointing to a specific pathogen: the gonococcal triad (N. gonorrhoeae), sickle cell disease increasing risk for encapsulated organisms (Salmonella), lack of immunizations with characteristic Gram-negative morphology (H. influenzae type b), and the healthy pediatric baseline (S. aureus).

Step-by-Step Solution

1

Evaluate the adolescent vignette focusing on the classic physical examination triad.

The combination of tenosynovitis, dermatitis, and migratory polyarthralgia in a sexually active patient specifically directs the diagnosis toward a disseminated gonococcal infection.

Recognizing this triad is essential to differentiate gonococcal arthritis from other causes of acute joint inflammation in young adults.

2

Identify the underlying hemoglobinopathy in the second vignette to determine specific infectious susceptibilities.

The patient with a hemoglobin structural variant (sickle cell disease) has a uniquely elevated risk for non-typhoidal Salmonella bone infections.

Functional asplenia and microinfarctions in the bone marrow create an environment highly susceptible to Salmonella bacteremia and subsequent osteomyelitis.

3

Utilize the vaccination status and microbiological findings in the third vignette.

The presence of pleomorphic Gram-negative coccobacilli in an unimmunized child strongly points to Haemophilus influenzae type b.

Routine Hib vaccination has made this presentation rare, but it remains a primary diagnostic consideration in the unimmunized population.

4

Assess the risk factors in the final vignette featuring an otherwise healthy child.

In the absence of underlying disease, Staphylococcus aureus is the overwhelmingly most frequent culprit of acute hematogenous osteomyelitis.

S. aureus commonly colonizes the skin and can easily cause transient bacteremia and bone seeding following minor superficial trauma.

Key Concept

Etiologic agents of pediatric osteoarticular infections are strongly correlated with patient age, underlying hematologic conditions, vaccination status, and sexual activity.

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept